Order Article Reprints

Madureira MB, Concato VM, Cruz EMS, Bitencourt de Morais JM, Inoue FSR, Concimo Santos N, Gonçalves MD, Cremer de Souza M, Basso Scandolara T, Fontana Mezoni M, et al. Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer. Antioxidants. 2023; 12(3):586. https://doi.org/10.3390/antiox12030586

Madureira, Maria Beatriz, Virginia Marcia Concato, Ellen Mayara Souza Cruz, Juliana Maria Bitencourt de Morais, Fabricio Seidy Ribeiro Inoue, Natália Concimo Santos, Manoela Daniele Gonçalves, Milena Cremer de Souza, Thalita Basso Scandolara, Mariane Fontana Mezoni, and et al. 2023. "Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer" Antioxidants 12, no. 3: 586. https://doi.org/10.3390/antiox12030586

Madureira, M. B., Concato, V. M., Cruz, E. M. S., Bitencourt de Morais, J. M., Inoue, F. S. R., Concimo Santos, N., Gonçalves, M. D., Cremer de Souza, M., Basso Scandolara, T., Fontana Mezoni, M., Galvani, M., Rodrigues Ferreira Seiva, F., Panis, C., Miranda-Sapla, M. M., & Pavanelli, W. R. (2023). Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer. Antioxidants, 12(3), 586. https://doi.org/10.3390/antiox12030586